Catalyst Wire Dossier Catalyst Wire Dossier

VIVJOA

oteseconazole · Mycovia Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VIVJOA, covering 2022-04-26 to 2024-04-11. Get the full timeline:

Most recent: FDA Approved: VIVJOA — Supplemental Application (Mycovia Pharmaceuticals, Inc.)

See pricing